Adastra – EN – InvestProfi.com

Adastra Labs Holdings Ltd.

WKN: A2PXHF / ISIN: CA00653U1030

More and more countries are legalizing the cannabis market. This offers enormous potential for companies like Adastra Labs Holdings Ltd.

Why this is so, we will explain below:

Adastra Labs Holdings Ltd. are in the process of becoming a standard cannabis processor and analytical testing laboratory in Canada.

The company has applied for its standard processing license, which it expects to receive in the near future, and its subsidiary Chemia Analytics has received a license for analytical testing from Health Canada.
When the company receives its standard processing license, Adastra Labs intends to become a one-stop shop for value-added cannabis concentrates and products.

With the market for cannabis extracts expected to reach USD 2.1 billion by 2020, CBD extracts are one of the fastest growing segments of the Canadian cannabis market.

Adastra Labs Holdings Ltd. owns an approximately 4,000 square meter former factory used for food processing/manufacturing in Langley, British Columbia.

The company is currently retrofitting the building, which was designed in accordance with GMP (Good Manufacturing Practices) guidelines.
The facility is expected to produce significant quantities of cannabis and hemp oil for the Canadian medical and recreational wholesale market.

The processing plant has an in-process testing laboratory operated by Chemia Analytics.
As the facility is being retrofitted, the company intends to continue the EU GMP certification required to enter the European cannabis market.
The laboratory is expected to provide a full range of third party analytical tests to licensed manufacturers.

Adastra Labs Holdings Ltd. intends to offer its B2B customers and partners a range of value-added products under several existing consumer-oriented brands.
The company currently offers its customers a high-THC or CBD distillate, bulk vape formulations, capsule formulations and water-soluble formulations.

To date, Adastra Labs Holdings Ltd. has a supply agreement with SugarBud Craft Growers Corp. (TSXV: SUGR ).

An extremely diverse team of scientists, consultants and executives lead Adastra Labs Holdings Ltd. with extensive experience in quality control and regulatory compliance in the cannabis industry.

Notable members of the team include CEO Andy Hale, Quality Assurance Manager Donald Dinsmore and Laboratory Manager Priyanka Nalawade.

Very good reasons for success:

The goal of Adastra Labs is to be a leading standard cannabis processor
The company’s B2B strategy bridges the gap between cannabis cultivators and extraction.
Adastra Labs plans to purchase cannabis concentrates from one source.
The subsidiary Chemia Labs has recently received the license for analytical tests from Health Canada

The company owns an approximately 4,000 square meter facility in Langley, British Columbia, which is being upgraded to GMP standards
Supply agreement with SugarBud
An extremely diverse team of scientists, consultants and managers with extensive experience in quality control and regulatory compliance in the cannabis industry

Processing plant from Adastra Labs

Adastra Labs Holdings Ltd. owns an approximately 4,000 square meter former food packaging facility in Langley, British Columbia.

The building is less than an hour’s drive from Vancouver Airport or downtown Vancouver.

The facility is one of the first buildings in the region to be zoned specifically for cannabis processing and testing.

Adastra Labs Holdings Ltd. is currently upgrading the building, which was designed to be GMP compliant.
Upon completion, the plant is expected to process more than 400,000 kilograms of dried cannabis per year and more than 30,000 liters of highly refined cannabis oil distillate.
The plant is also expected to house a secure storage facility of approximately 4,500 square meters, which can hold more than 7,500 kilograms of dried cannabis while providing space for finished products.

Chemistry Analytics
The Adastra Labs processing facility houses an in-process test laboratory, which is operated by the subsidiary Chemia Analytics. As the facility is being retrofitted, Chemia intends to continue with ISO 17025 certification to complement the processing facility’s compliance with GMP standards. Chemia recently received its analytical testing license from Health Canada.

Efficacy testing
Cannabinoid profiling
Pesticide screening
Mycotoxin analysis
Heavy metal analysis
Microbial contamination

The company plans to combine Chemia’s testing services with its white label and toll processing services to provide a time-saving and cost-effective solution for customers.

Products from Adastra Labs

To take advantage of the second round of cannabis legalization, Adastra Labs has developed several types of products that the company wants to offer to its B2B customers. The value-added products of Adastra Labs include

A distillate with a high THC or CBD content (CBD is the abbreviation for cannabidiol, a chemical substance from the class of cannabinoids. CBD and THC are very similar in structure and have the same chemical formula. Also, appearance and smell can hardly be distinguished – CBD, however, has slight variations in molecular structure and is therefore not psychotropic and does not affect the central nervous system)
Bulk Vape Formulations
Capsule Formulations
Water soluble formulations

Adastra Labs Holdings Ltd. also intend to expand its product offering to include cannabinoid isolates.

Business model of Adastra Labs

Contract processing, white label production and cannabis testing

Adastra Labs Holdings Ltd. offers white label and contract processing services to growers who choose to outsource their cannabis production and processing.

Through its white-label and toll processing services, the company is able to offer its customers turnkey solutions tailored to the specific needs of each customer.

Adastra Labs Holdings Ltd. also offers third-party cannabis testing services to Canadian licensed growers through the company’s state-of-the-art testing laboratory. Third party control testing is a requirement that all licensed manufacturers must comply with.

Clients
Adastra Labs Holdings Ltd. have signed a supply contract with SugarBud for dried and cut flowers. Under the terms of the agreement, SugarBud Adastra Labs Holdings Ltd. is expected to supply at least 900kg grams of premium cannabis flowers over a period of nine months.
Adastra Labs Holdings Ltd. hopes to further develop its relationship with SugarBud.

This is the first of many partnerships Adastra Labs Holdings Ltd. has entered into.

In an interview with Stockhouse Editorial, CEO of Adastra Labs Holdings Ltd., Andy Hale explained that negotiations with other major partnerships are underway.

Adastra Labs Holdings Ltd. offers “premium partnerships” to cannabis companies that benefit from this emerging market. What the company is bringing to the table is a means of meeting processing requirements and testing process quality. This includes everyone from artisan growers to well-known national brands.
The company is supported by a strong team with solid scientific knowledge and industry consultants with many years of experience.

Management Team of Adastra Labs

Andy Hale

MBA, BSAE, PMP - CEO, Co-Founder and Director

Andy Hale has over 35 years experience in leading high performance technical teams in regulated environments covering the US Navy. There he commanded three nuclear-powered submarines for a $3 billion Canadian government shipbuilding portfolio at Seaspan Shipyard.

Steve Brohman

CPA, CA - CFO

Steve Brohman has extensive experience as CFO and Director of various public and private companies in Canada, the United States and Europe with a focus on CSE, TSXV and OTC listed companies. He has led public and private capital raising, acquisitions and executive management committees.

Blaine Bailey

CPA, CGA, B. Comm. - Director

Blaine Bailey ist ein erfahrener unabhängiger Direktor, Chief Financial Officer und Controller für öffentliche und private Unternehmen in Kanada. Er verfügt über umfangreiche Erfahrung als CFO im Bergbausektor sowie in öffentlichen und privaten Unternehmen. Er war der ehemalige Controller für Nabob Coffee Co., eines der größten kanadischen Kaffeeunternehmen.

Georges E. Routhier

Director

Georges Routhier is CEO of PipeDreemz Inc, a leading cannabis licensing consultancy that has been responsible for the successful licensing of nearly 30 percent of cannabis-licensed producers across Canada over the past six years. He has had a long and distinguished career in the high technology sector.

Priyanka Nalawade

Laboratory Manager

With a PhD in Polymer Engineering, she is the lead R&D chemist with extensive experience in the synthesis and characterization of novel high-performance polymers from renewable sources. She received her Bachelor of Technology in Polymer Engineering from the Institute of Chemical Technology in Mumbai, India and a PhD in Polymer Engineering from the University of Akron, Ohio.

more Information:

Adastra Labs Holdings Ltd.
Stephen Brohman, Director

steve@adastralabs.ca

604-710-6657

Disclaimer

The information contained herein has been obtained from sources believed to be reliable, but in no way claims to be accurate or complete. Due to court decisions, the contents of linked external pages are also to be answered for (e.g. Landgericht Hamburg, in the decision of 12.05.1998 - 312 O 85/98), as long as there is no explicit dissociation from them. Despite careful control of the contents, the author does not assume any liability for the contents of linked external pages. The operators of these sites are solely responsible for their content. The author of this article may hold shares of presented shares in his personal portfolio. These shares were purchased on the market. The information contained in this article is for information purposes only and does not constitute an invitation to buy or sell securities, but only reflects the opinion of the author. The author assumes no liability for financial losses, errors excepted! Stock exchange transactions, especially futures transactions, involve risks that can lead to a total loss of the capital invested and beyond! All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. The author expressly reserves the right to make mistakes, particularly with regard to figures and prices, despite the greatest care. Investments in securities, shares and currencies are associated with risks. They can lead to considerable losses of the invested capital in addition to the income. If the security or share is acquired in a currency other than the euro, exchange rate risks can also arise for the investor. Money management and risk management are important.